Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Syneos Health Inc
(NQ:
SYNH
)
42.98
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Sep 27, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Syneos Health Inc
< Previous
1
2
3
4
Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
August 02, 2022
Via
Benzinga
Recap: Syneos Health Q2 Earnings
August 02, 2022
Syneos Health (NASDAQ:SYNH) reported its Q2 earnings results on Tuesday, August 2, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
May 24, 2022
Upgrades
Via
Benzinga
Syneos Health Shares Jump On Better Than Expected Q1 Earnings, FY22 Outlook
April 29, 2022
Via
Benzinga
Syneos Health: Q1 Earnings Insights
April 29, 2022
Syneos Health (NASDAQ:SYNH) reported its Q1 earnings results on Friday, April 29, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
April 26, 2022
During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.
Via
Benzinga
Earnings Scheduled For August 2, 2022
August 02, 2022
Companies Reporting Before The Bell • Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.
Via
Benzinga
Recap: Syneos Health Q4 Earnings
February 17, 2022
Syneos Health (NASDAQ:SYNH) reported its Q4 earnings results on Thursday, February 17, 2022 at 06:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Syneos Health's Return On Capital Employed Insights
May 06, 2022
Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) posted Q1 earnings of $46.18 million, an increase from Q4 of 39.21%. Sales dropped to $1.34 billion, a 2.69% decrease between quarters.
Via
Benzinga
Earnings Scheduled For April 29, 2022
April 29, 2022
Companies Reporting Before The Bell • Weyerhaeuser (NYSE:WY) is projected to report quarterly earnings at $1.19 per share on revenue of $2.93 billion.
Via
Benzinga
A Preview Of Syneos Health's Earnings
April 28, 2022
Syneos Health (NASDAQ:SYNH) is set to give its latest quarterly earnings report on Friday, 2022-04-29. Here's what investors need to know before the announcement. Analysts estimate that Syneos Health...
Via
Benzinga
Earnings Scheduled For February 17, 2022
February 17, 2022
Companies Reporting Before The Bell • Palantir Technologies (NYSE:PLTR) is estimated to report quarterly earnings at $0.04 per share on revenue of $417.69 million.
Via
Benzinga
Analyst Ratings For Syneos Health
January 27, 2022
Within the last quarter, Syneos Health (NASDAQ:SYNH) has observed the following analyst ratings:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
April 25, 2022
Via
Benzinga
Looking Into Syneos Health's Return On Capital Employed
February 18, 2022
Pulled from Benzinga Pro data, Syneos Health (NASDAQ:SYNH) showed a loss in earnings since Q3, totaling $75.96 million. Sales, on the other hand, increased by 1.84% to $1.37 billion during Q4.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 12, 2022
April 12, 2022
Upgrades
Via
Benzinga
The Daily Biotech Pulse: J&J Unit Announces Research Collaboration With Remix, Regencell Touts COVID Data, Decision Day For Agios
February 17, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Amylyx's ALS Treatment Regulatory Application To Be Reviewed By FDA Panel...
Via
Benzinga
Syneos Health Reports Mixed Q4 Earnings, Provides FY22 Guidance
February 17, 2022
Syneos Health Inc's (NASDAQ: SYNH) Q4 revenue increased 20.5% on a reported basis and 20.8% on a constant currency (CC) basis to
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 15, 2021
December 15, 2021
Upgrades B of A Securities upgraded the previous rating for ONE Gas Inc (NYSE:
Via
Benzinga
Labcorp In Talks To Merge Some Covance Assets With Syneos: Bloomberg
November 12, 2021
Laboratory Corp of America Holdings (NYSE: LH) is in talks to combine some of its assets with Syneos Health Inc (NASDAQ: SYNH), reports Bloomberg citing...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For November 5, 2021
November 05, 2021
Upgrades For IGM Biosciences Inc (NASDAQ:
Via
Benzinga
Syneos Health, inc (SYNH) Q3 2021 Earnings Call Transcript
November 03, 2021
SYNH earnings call for the period ending September 30, 2021.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Syneos Health's Return On Capital Employed Overview
November 03, 2021
According to Benzinga Pro, during Q3, Syneos Health (NASDAQ:SYNH) earned $113.36 million, a 35.46% increase from the preceding quarter. Syneos Health also posted a total of $1.35...
Via
Benzinga
The Daily Biotech Pulse: Cerus Climbs On Earnings, Horizon CFO To Retire, Teva Prices Upsized Sustainability-Linked Senior Note Offering
November 03, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Horizon Announces Retirement Of CFO, Beat-and-raise Q3 Horizon Therapeutics...
Via
Benzinga
Topics
Retirement
Exposures
Pension
The Daily Biotech Pulse: FDA Nod For Lilly, Regulus Slumps On Study Discontinuation, ObSeva Strikes Linzagolix Commercialization Deal
October 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Revance Clarifies Gabellar Line Treatment Review On Track Responding to the...
Via
Benzinga
Exposures
Product Safety
Looking Into Syneos Health's Return On Capital Employed
September 13, 2021
According to Benzinga Pro, during Q2, Syneos Health (NASDAQ:SYNH) earned $83.68 million, a 37.15% increase from the preceding quarter. Syneos Health also posted a total of $1.28...
Via
Benzinga
Earnings Scheduled For November 3, 2021
November 03, 2021
Companies Reporting Before The Bell • R.R.Donnelley & Sons (NYSE:RRD) is likely to report quarterly earnings at $0.32 per share on revenue of $1.19 billion....
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs
September 15, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 14) Alcon Inc. (NYSE: ALC)...
Via
Benzinga
Exposures
COVID-19
The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout
September 14, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...
Via
Benzinga
Exposures
COVID-19
< Previous
1
2
3
4
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.